Chrome Extension
WeChat Mini Program
Use on ChatGLM

Adjuvant Tislelizumab Combined with Capecitabine for Patients with Biliary Tract Cancer with High Risk of Postoperative Relapse (ACTIVE): Primary Analysis from a Prospective Cohort Study.

Journal of Clinical Oncology(2024)

Cited 0|Views6
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined